Taken together, these results suggest a significant role for RhoA in promoting macrophage infiltration into calcification sites and pro-inflammatory activity in dKO skeletal and cardiac muscle and consequently the inhibition of RhoA may represent a therapeutic target to improve the muscle pathology observed in DMD patients. Here, RHOA is linked to Duchenne muscular dystrophy.